Your browser doesn't support javascript.
loading
A Functional Role for Antibodies in Tuberculosis.
Lu, Lenette L; Chung, Amy W; Rosebrock, Tracy R; Ghebremichael, Musie; Yu, Wen Han; Grace, Patricia S; Schoen, Matthew K; Tafesse, Fikadu; Martin, Constance; Leung, Vivian; Mahan, Alison E; Sips, Magdalena; Kumar, Manu P; Tedesco, Jacquelynne; Robinson, Hannah; Tkachenko, Elizabeth; Draghi, Monia; Freedberg, Katherine J; Streeck, Hendrik; Suscovich, Todd J; Lauffenburger, Douglas A; Restrepo, Blanca I; Day, Cheryl; Fortune, Sarah M; Alter, Galit.
Afiliação
  • Lu LL; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
  • Chung AW; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Microbiology and Immunology, Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia.
  • Rosebrock TR; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
  • Ghebremichael M; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Yu WH; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
  • Grace PS; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Schoen MK; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Tafesse F; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Martin C; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
  • Leung V; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA.
  • Mahan AE; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Sips M; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Biomedical Molecular Biology, Ghent University, Ghent 9000, Belgium.
  • Kumar MP; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
  • Tedesco J; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Robinson H; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Tkachenko E; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Draghi M; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Freedberg KJ; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Streeck H; Institute for Medical Biology, University Hospital Essen, University of Duisburg-Essen, 45141 Essen, Germany.
  • Suscovich TJ; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Lauffenburger DA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
  • Restrepo BI; School of Public Health, University of Texas Health Houston, Brownsville, TX 78520, USA.
  • Day C; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30307, USA; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30332, USA; South African Tuberculosis Vaccine Initiative (SATVI) and School of Child and Adolescent Health, Institute of Inf
  • Fortune SM; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115, USA. Electronic address: sfortune@hsph.harvard.edu.
  • Alter G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA. Electronic address: galter@mgh.harvard.edu.
Cell ; 167(2): 433-443.e14, 2016 Oct 06.
Article em En | MEDLINE | ID: mdl-27667685
ABSTRACT
While a third of the world carries the burden of tuberculosis, disease control has been hindered by a lack of tools, including a rapid, point-of-care diagnostic and a protective vaccine. In many infectious diseases, antibodies (Abs) are powerful biomarkers and important immune mediators. However, in Mycobacterium tuberculosis (Mtb) infection, a discriminatory or protective role for humoral immunity remains unclear. Using an unbiased antibody profiling approach, we show that individuals with latent tuberculosis infection (Ltb) and active tuberculosis disease (Atb) have distinct Mtb-specific humoral responses, such that Ltb infection is associated with unique Ab Fc functional profiles, selective binding to FcγRIII, and distinct Ab glycosylation patterns. Moreover, compared to Abs from Atb, Abs from Ltb drove enhanced phagolysosomal maturation, inflammasome activation, and, most importantly, macrophage killing of intracellular Mtb. Combined, these data point to a potential role for Fc-mediated Ab effector functions, tuned via differential glycosylation, in Mtb control.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interações Hospedeiro-Patógeno / Tuberculose Latente / Imunidade Humoral / Anticorpos Antibacterianos / Mycobacterium tuberculosis Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interações Hospedeiro-Patógeno / Tuberculose Latente / Imunidade Humoral / Anticorpos Antibacterianos / Mycobacterium tuberculosis Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article